Jay A. Fishman Ltd’s AbbVie ABBV Stock Holding History

Jay A. Fishman Ltd’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.1M	Sell	67,770 -497	-0.7%	-$107K	1.36%	18
2026 Q1	$14.8M	Sell	68,267 -1,080	-2%	-$240K	1.33%	19
2025 Q4	$15.8M	Sell	69,347 -175	-0.3%	-$39.9K	1.3%	21
2025 Q3	$16.1M	Sell	69,522 -150	-0.2%	-$30.5K	1.38%	18
2025 Q2	$12.9M	Buy	69,672 +460	+0.7%	+$85.5K	1.24%	19
2025 Q1	$14.5M	Buy	69,212 +305	+0.4%	+$59.3K	1.58%	15
2024 Q4	$12.2M	Buy	68,907 +954	+1%	+$175K	1.15%	19
2024 Q3	$13.4M	Sell	67,953 -542	-0.8%	-$101K	1.33%	17
2024 Q2	$11.7M	Sell	68,495 -1,650	-2%	-$273K	1.24%	19
2024 Q1	$12.8M	Buy	70,145 +755	+1%	+$130K	1.41%	17
2023 Q4	$10.8M	Sell	69,390 -2,446	-3%	-$357K	1.23%	19
2023 Q3	$10.7M	Sell	71,836 -6,243	-8%	-$916K	1.36%	19
2023 Q2	$10.5M	Sell	78,079 -93,693	-55%	-$13.7M	1.27%	20
2023 Q1	$27.4M	Sell	171,772 -1,020	-0.6%	-$156K	3.5%	9
2022 Q4	$27.9M	Buy	172,792 +335	+0.2%	+$51.4K	3.93%	8
2022 Q3	$23.1M	Buy	172,457 +1,430	+0.8%	+$205K	3.35%	8
2022 Q2	$26.2M	Buy	171,027 +1,697	+1%	+$259K	3.57%	8
2022 Q1	$27.5M	Buy	169,330 +5,554	+3%	+$807K	3.02%	9
2021 Q4	$22.2M	Buy	163,776 +22,510	+16%	+$2.66M	2.37%	15
2021 Q3	$15.2M	Buy	141,266 +49,595	+54%	+$5.67M	1.89%	15
2021 Q2	$10.3M	Buy	91,671 +25,065	+38%	+$2.82M	1.26%	18
2021 Q1	$7.21M	Buy	66,606 +32,240	+94%	+$3.45M	0.97%	22
2020 Q4	$3.68M	Buy	34,366 +31,560	+1,125%	+$3.03M	0.51%	30
2020 Q3	$246K	Buy	+2,806	New	+$264K	0.04%	83
2019 Q2	–	Sell	-8,556	Closed	-$690K	–	84
2019 Q1	$690K	Sell	8,556 -45	-0.5%	-$3.68K	0.13%	55
2018 Q4	$793K	Buy	8,601 +45	+0.5%	+$3.96K	0.17%	53
2018 Q3	$809K	Hold	8,556	–	–	0.14%	53
2018 Q2	$793K	Hold	8,556	–	–	0.15%	53
2018 Q1	$810K	Sell	8,556 -500	-6%	-$54.9K	0.15%	55
2017 Q4	$876K	Hold	9,056	–	–	0.17%	55
2017 Q3	$805K	Sell	9,056 -300	-3%	-$22.8K	0.16%	60
2017 Q2	$678K	Sell	9,356 -92	-1%	-$6.18K	0.14%	58
2017 Q1	$616K	Buy	9,448 +92	+1%	+$5.78K	0.14%	61
2016 Q4	$586K	Hold	9,356	–	–	0.14%	63
2016 Q3	$590K	Hold	9,356	–	–	0.15%	60
2016 Q2	$579K	Hold	9,356	–	–	0.15%	62
2016 Q1	$534K	Hold	9,356	–	–	0.14%	64
2015 Q4	$554K	Hold	9,356	–	–	0.13%	65
2015 Q3	$509K	Hold	9,356	–	–	0.12%	68
2015 Q2	$629K	Buy	9,356 +300	+3%	+$19.6K	0.13%	67
2015 Q1	$530K	Hold	9,056	–	–	0.11%	74
2014 Q4	$593K	Hold	9,056	–	–	0.13%	71
2014 Q3	$523K	Hold	9,056	–	–	0.12%	68
2014 Q2	$511K	Hold	9,056	–	–	0.11%	72
2014 Q1	$465K	Hold	9,056	–	–	0.1%	72
2013 Q4	$478K	Hold	9,056	–	–	0.11%	73
2013 Q3	$405K	Hold	9,056	–	–	0.1%	76
2013 Q2	$374K	Buy	+9,056	New	+$396K	0.1%	78

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jay A. Fishman Ltd's ABBV Position: Q2 2026 in Review

Jay A. Fishman Ltd reduced its AbbVie (ABBV) stake by 0.73% in Q2 2026, selling an estimated $107K and leaving 67,770 shares worth $17.1M. The position accounts for 1.36% of the portfolio, ranked #18.

Jay A. Fishman Ltd first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $27.9M in Q4 2022. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Jay A. Fishman Ltd held 67,770 shares of AbbVie worth $17.1M as of Q2 2026.
Jay A. Fishman Ltd sold 497 AbbVie shares in Q2 2026, an estimated $107K.
AbbVie made up 1.36% of Jay A. Fishman Ltd's portfolio in Q2 2026, its #18 holding.
Jay A. Fishman Ltd first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
Jay A. Fishman Ltd's AbbVie position peaked at $27.9M in Q4 2022.
4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jay A. Fishman Ltd's 13F filing for Q2 2026, filed 29 Jul 2026.